These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 1850506

  • 21. Vaccination of children with malignant disease against varicella.
    Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO.
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T, Iseki K, Oka R, Sakuma S, Yoshioka H, Takahashi M.
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [Abstract] [Full Text] [Related]

  • 23. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [Abstract] [Full Text] [Related]

  • 24. [Varicella vaccination].
    Heidl M, Scholz H.
    Padiatr Grenzgeb; 1990 Jun; 29(1):31-6. PubMed ID: 2160635
    [Abstract] [Full Text] [Related]

  • 25. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y, Osawa S, Takahashi R.
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [Abstract] [Full Text] [Related]

  • 26. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM.
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [Abstract] [Full Text] [Related]

  • 27. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S.
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract] [Full Text] [Related]

  • 28. Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination.
    Asano Y, Hirose S, Iwayama S, Miyata T, Yazaki T, Takahashi M.
    Biken J; 1982 Mar; 25(1):43-5. PubMed ID: 6289799
    [Abstract] [Full Text] [Related]

  • 29. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [Abstract] [Full Text] [Related]

  • 30. A role for genetics in the immune response to the varicella vaccine.
    Klein NP, Fireman B, Enright A, Ray P, Black S, Dekker CL, Clinical Immunization Safety Assessment Network.
    Pediatr Infect Dis J; 2007 Apr; 26(4):300-5. PubMed ID: 17414391
    [Abstract] [Full Text] [Related]

  • 31. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K.
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [Abstract] [Full Text] [Related]

  • 32. [Active chickenpox vaccination of children with acute leukemia or other neoplastic diseases].
    Haas RJ, Belohradsky B, Dickerhoff R, Eichinger K, Eife R, Holtmann H, Goetz O, Graubner U, Peller P.
    Klin Padiatr; 1985 Sep; 197(6):477-80. PubMed ID: 3003449
    [Abstract] [Full Text] [Related]

  • 33. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [Abstract] [Full Text] [Related]

  • 34. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine.
    Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S.
    Pediatrics; 1977 Jan; 59(1):3-7. PubMed ID: 190583
    [Abstract] [Full Text] [Related]

  • 35. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS, Brown ML, Xu J, Sullivan BJ, Marshall GS, Nauert B, Matson DO, Silas PE, Schödel F, Gress JO, Kuter BJ, Protocol 014 Study Group for ProQuad.
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [Abstract] [Full Text] [Related]

  • 36. Varicella vaccine studies in healthy children and adults.
    Arbeter AM, Starr SE, Plotkin SA.
    Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [Abstract] [Full Text] [Related]

  • 37. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A.
    Clin Infect Dis; 2002 Mar 15; 34(6):774-9. PubMed ID: 11830801
    [Abstract] [Full Text] [Related]

  • 38. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A, Coovadia HM, Jugnundan P, Haffejee IE, Meurice F, Vandevoorde D.
    S Afr Med J; 1995 Dec 15; 85(12):1295-8. PubMed ID: 8600589
    [Abstract] [Full Text] [Related]

  • 39. Humoral immunity and clinical reinfections following varicella vaccine in healthy children.
    Johnson C, Rome LP, Stancin T, Kumar ML.
    Pediatrics; 1989 Sep 15; 84(3):418-21. PubMed ID: 2549498
    [Abstract] [Full Text] [Related]

  • 40. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 2007 Jul 15; 26(7):572-6. PubMed ID: 17596796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.